Clear Search

Books+ Search Results

Location: Is
Is Is Not
Marx Library
Subject with Hierarchy: Is
Is Is Not
Pharmaceutical industry

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

1.
Drug shortage health and national security risks : underlying causes and needed reforms : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, first session, March 22, 2023
Author
United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs, author
Published
Washington : U.S. Government Publishing Office, 2023.
Location
Library Shelving Facility (LSF) >> Y 4.G 74/9:S.HRG.118-56
Format
Books
2.
Pharmanomics : how big pharma destroys global health
Author
Dearden, Nick
Published
London ; Brooklyn, NY : Verso, 2023.
©2023
Location
MARX Library >> HD9665.5 .D396 2023 (LC)
Format
Books
3.
The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session
Author
United States. Congress. House. Committee on Oversight and Accountability, author
Published
Washington : U.S. Government Publishing Office, 2023.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:118-36
Format
Books
4.
Healthcare finance : modern financial analysis for accelerating biomedical innovation
Author
Lo, Andrew W. (Andrew Wen-Chuan)
Published
Princeton, New Jersey : Princeton University Press, [2022]
©2023
Location
MARX Library, 2-hour Reserve, ask at Info Desk >> RA971.3 L6 2022 (LC)
Format
Books
5.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington, DC : United States Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:117-11
Format
Books
6.
No time to wait : proposals to lower prescription drug costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Phoenix, Arizona, April 12, 2022
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.AG 4:S.HRG.117-249
Format
Books
7.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-63
Format
Books
8.
Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-76
Format
Books
9.
Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.AG 4:S.HRG.114-846
Format
Books
10.
Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-37
Format
Books
11.
Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : United States Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-32
Format
Books
12.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-17
Format
Books
13.
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:116-42
Format
Books
14.
The SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:117-27
Format
Books
15.
Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.115-727
Format
Books
16.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-25
Format
Books
17.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-21
Format
Books
18.
Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020-2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-123
Format
Books
19.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019-
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.116-39
Format
Books
20.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:115-96
Format
Books
21.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-01
Format
Books
22.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-24
Format
Books
23.
The patient perspective : the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 26, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-55
Format
Books
24.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:115-28
Format
Books
25.
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.114-805
Format
Books